[1]
Acampa M, Lazzerini PE, Guideri F, et al. Electrocardiographic predictors of silent atrial fibrillation in cryptogenic stroke. Heart Lung Circ 2019; 28(11): 1664-9.
[2]
Acampa M, Lazzerini PE, Guideri F, et al. Inflammation and atrial electrical remodelling in patients with embolic strokes of undetermined source. Heart Lung Circ 2019; 28(6): 917-22.
[3]
Lazzerini PE, Bertolozzi I, Acampa M, et al. Androgen deprivation therapy for prostatic cancer in patients with torsades de pointes. Front Pharmacol 2020 May 13; 11: 684.
[4]
Giustozzi M, Acciarresi M, Agnelli G, et al. Safety of anticoagulation in patients treated with urgent reperfusion for ischemic stroke related to atrial fibrillation. Stroke 2020 Aug; 51(8): 2347-54.
[5]
Acampa M, Lazzerini PE, Manfredi C, et al. Non-stenosing carotid atherosclerosis and arterial stiffness in embolic stroke of undetermined source. Front Neurol 2020 Jul 24; 11: 725.
[http://dx.doi.org/10.3389/fneur.2020.00725]
[http://dx.doi.org/10.3389/fneur.2020.00725]
[6]
Lazzerini PE, Acampa M, Laghi-Pasini F, et al. Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression. Circ Arrhythm Electrophysiol 2020 Aug; 13(8): e008627.
[7]
Lazzerini PE, Laghi-Pasini F, Acampa M, et al. IL-6 (Interleukin 6) blockade and heart rate corrected QT interval prolongation in COVID-19. Circ Arrhythm Electrophysiol 2020 Sep; 13(9): e008791.
[8]
Guideri F, Acampa M, Hayek Y, Zappella M. Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden death? Pediatr Cardiol 2005; 26(5): 574-7.
[9]
Bellieni CV, Acampa M, Maffei M. Electromagnetic fields produced by incubators influence heart rate variability in newborns. Arch Dis Child Fetal Neonatal Ed 2008; 93(4): F298-301.
[10]
Acampa M, Lazzerini PE, Guideri F. Ischemic Stroke after Heart Transplantation. J Stroke 2016; 18(2): 157-68.